Tag: Massey Cancer Center
A protein called GRP78 could be a universal therapeutic target for treating human diseases like brain cancer, Ebola, Influenza, Hepatitis and superbug bacteria such as MRSE and MRSA, according to a Virginia Commonwealth University-led pre-clinical study published this month in the Journal of Cellular Physiology.
The Center for the Study of Tobacco Products at Virginia Commonwealth University has been named a World Health Organization collaborating center that will assist the global health organization with questions related to tobacco product testing and research.
Researchers at VCU have been approved for a three-year, $749,000 funding award to demonstrate a new method for engaging stakeholders, especially patients, in framing research.
Virginia will partner with The V Foundation for Cancer Research to host “Virginia Vine: The Commonwealth Crushes Cancer,” a weekend event to be held in April 2015 at Trump Winery and other locations in Charlottesville.
Jason Reed, Ph.D., an assistant professor at VCU, has been awarded a roughly $2 million grant with a collaborator at UCLA to develop a new method to rapidly determine how a cancerous tumor responds to a battery of candidate therapies.